Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News and Views
Nature Reviews Urology 6, 582–583 (1 November 2009) | doi:10.1038/nrurol.2009.212
Bladder cancer: Brachytherapy-based bladder sparing alternative to cystectomy
&
Abstract
Radical cystectomy is considered the optimal therapy for the treatment of bladder cancer when a bladder preservation approach is not in the best interest of the patient; for example if transurethral resection of bladder tumor (TURBT) and intravesical therapy have failed in patients with high-risk noninvasive (high-grade Ta–T1) or muscle-invasive bladder cancer. However, radical cystectomy is associated with complication rates of 17–32% and 1–2% perioperative mortality, which are largely dependent on the patient's age and comorbidity.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
